Quarterly Activities Report & Appendix 4C
Filed with ASX · · 8 pages · English
• Group sales revenue for Q2 FY26 was $5.3m (-19% QoQ, -13% pcp), taking YTD Group sales revenue to $11.9m at 31 December 2025. The quarter reflected steady performance in the core Oli6® channel (Q2 revenue $4.0m, flat QoQ), partially offset by lower Practitioner revenue (Q2 revenue $1.3m, down 48% QoQ). • Oli6® Nutritionals delivered Q2 sales revenue of $4.0m, bringing YTD sales revenue to $8.0m,
Story so far
Earlier from Nuchev Pty
- Nuchev Secures Working Capital Facility
- FY25 Financial Reporting and Summary
- FY25 Results and Business Update Presentation
- Appendix 4E
- H&S Group Exercise Performance Options
Later from Nuchev Pty
- Appendix 4D and Half Year Report
- Investor Presentation - Half Year Results to 31 Dec 25
- Nuchev enters into Distribution Agreement with H&S
- Appendix 4C and Quarterly Activities Report
- Quarterly Activities Report and Appendix 4C
Follow Nuchev Pty into a list and get an email when it puts out news.
Follow Nuchev Pty